Yuko Nakamura1, Tadanobu Nagaya1, Kazuhide Sato1, Shuhei Okuyama1, Fusa Ogata1, Karen Wong1, Stephen Adler2, Peter L Choyke1, Hisataka Kobayashi3. 1. Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and. 2. Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., National Cancer Institute Campus at Frederick, Frederick, Maryland. 3. Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and kobayash@mail.nih.gov.
Abstract
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with toxicity induced by photoabsorbers after irradiation with NIR light. A limitation of NIR-PIT is the inability to deliver NIR light to a tumor located deep inside the body. Cerenkov radiation (CR) is the ultraviolet and blue light that is produced by a charged particle traveling through a dielectric medium faster than the speed of light in that medium and is commonly produced during radioactive decay. Here, we demonstrate the feasibility of using CR generated by 18F-FDG accumulated in tumors to induce photoimmunotherapy. Methods: Using A431-luc cells, we evaluated the therapeutic effects of CR-PIT in vitro and in vivo using bioluminescence imaging. Results: CR-PIT showed significant suppression of tumor size, but the decrease of bioluminescence after CR-PIT was not observed consistently over the entire time course. Conclusion: Although CR-PIT can induce tumor killing deep within body, it is less effective than NIR-PIT, possibly related to the relatively lower efficiency of short wavelength light than NIR.
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with toxicity induced by photoabsorbers after irradiation with NIR light. A limitation of NIR-PIT is the inability to deliver NIR light to a tumor located deep inside the body. Cerenkov radiation (CR) is the ultraviolet and blue light that is produced by a charged particle traveling through a dielectric medium faster than the speed of light in that medium and is commonly produced during radioactive decay. Here, we demonstrate the feasibility of using CR generated by 18F-FDG accumulated in tumors to induce photoimmunotherapy. Methods: Using A431-luc cells, we evaluated the therapeutic effects of CR-PIT in vitro and in vivo using bioluminescence imaging. Results:CR-PIT showed significant suppression of tumor size, but the decrease of bioluminescence after CR-PIT was not observed consistently over the entire time course. Conclusion: Although CR-PIT can induce tumor killing deep within body, it is less effective than NIR-PIT, possibly related to the relatively lower efficiency of short wavelength light than NIR.
Authors: Huiyun Lin; Rongxiao Zhang; Jason R Gunn; Tatiana V Esipova; Sergei Vinogradov; David J Gladstone; Lesley A Jarvis; Brian W Pogue Journal: Phys Med Biol Date: 2016-04-27 Impact factor: 3.609
Authors: Bradley J Beattie; Daniel L J Thorek; Charles R Schmidtlein; Keith S Pentlow; John L Humm; Andreas H Hielscher Journal: PLoS One Date: 2012-02-20 Impact factor: 3.240
Authors: Uriel Gallaga-González; Enrique Morales-Avila; Eugenio Torres-García; José A Estrada; Luis Enrique Díaz-Sánchez; German Izquierdo; Liliana Aranda-Lara; Keila Isaac-Olivé Journal: ACS Omega Date: 2022-06-30